Tyramine-induced vasodilation mediated by dopamine contamination: a paradox resolved.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 15967868)

Published in Hypertension on June 20, 2005

Authors

Giris Jacob1, Alfredo Gamboa, André Diedrich, Cyndya Shibao, David Robertson, Italo Biaggioni

Author Affiliations

1: Jacob Recanati Autonomic Dysfunction Center, Department of Internal Medicine C, Rambam Medical Center, Haifa, Israel.

Articles by these authors

Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res (2011) 3.88

Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol (2006) 3.24

Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation (2005) 2.39

Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension (2010) 2.38

AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation In Collaboration With the Heart Rhythm Society. J Am Coll Cardiol (2006) 2.38

Autonomic contribution to blood pressure and metabolism in obesity. Hypertension (2006) 2.25

Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype. Hypertension (2004) 2.18

Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells. J Immunol (2011) 2.05

The sympathetic nervous system in hypertension: assessment by blood pressure variability and ganglionic blockade. J Hypertens (2003) 1.98

Adenosine receptors in regulation of dendritic cell differentiation and function. Blood (2008) 1.91

Postural pseudoanemia: posture-dependent change in hematocrit. Mayo Clin Proc (2005) 1.89

AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society. Circulation (2006) 1.86

Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension (2006) 1.85

Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci (2011) 1.82

Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension (2005) 1.80

Clinical and translational research studios: a multidisciplinary internal support program. Acad Med (2012) 1.78

Clinical research subject recruitment: the Volunteer for Vanderbilt Research Program www.volunteer.mc.vanderbilt.edu. J Am Med Inform Assoc (2005) 1.76

Water ingestion as prophylaxis against syncope. Circulation (2003) 1.76

Women have lower tonic autonomic support of arterial blood pressure and less effective baroreflex buffering than men. Circulation (2005) 1.75

Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors. Circ Res (2003) 1.71

Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension (2007) 1.70

Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension (2010) 1.69

Neurovascular dissociation with paradoxical forearm vasodilation during systemic tyramine administration. Circulation (2003) 1.68

Renal impairment of pure autonomic failure. Hypertension (2009) 1.67

Four faces of baroreflex failure: hypertensive crisis, volatile hypertension, orthostatic tachycardia, and malignant vagotonia. Circulation (2002) 1.67

Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells. Circ Res (2007) 1.65

Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation. Circ Res (2002) 1.64

Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin Cancer Res (2007) 1.61

Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation (2009) 1.61

Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Heart Rhythm (2012) 1.60

Water drinking as a treatment for orthostatic syndromes. Am J Med (2002) 1.60

Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol (2004) 1.57

Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation (2005) 1.57

Bronchial artery embolization for hemoptysis in young patients with cystic fibrosis. Radiology (2002) 1.57

Estimation of sleep disturbances using wrist actigraphy in patients with postural tachycardia syndrome. Auton Neurosci (2013) 1.57

Human muscle sympathetic neural and haemodynamic responses to tilt following spaceflight. J Physiol (2002) 1.56

An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis. Angiogenesis (2007) 1.56

Sleep disturbances and diminished quality of life in postural tachycardia syndrome. J Clin Sleep Med (2011) 1.51

Management of hypertension in the setting of autonomic failure: a pathophysiological approach. Hypertension (2005) 1.51

Sodium paradoxically reduces the gastropressor response in patients with orthostatic hypotension. Hypertension (2006) 1.51

Actin-myosin-based contraction is responsible for apoptotic nuclear disintegration. J Cell Biol (2005) 1.49

A(2B) adenosine receptors increase cytokine release by bronchial smooth muscle cells. Am J Respir Cell Mol Biol (2003) 1.46

Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J Immunol (2004) 1.44

Orthostatic hypotension-related hospitalizations in the United States. Am J Med (2007) 1.43

Host A(2B) adenosine receptors promote carcinoma growth. Neoplasia (2008) 1.43

Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines. J Pharmacol Exp Ther (2007) 1.40

The Valsalva maneuver: screening for drug-induced baroreflex dysfunction. Clin Auton Res (2008) 1.38

A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion. PLoS One (2010) 1.34

Traumatic events, migration characteristics and psychiatric symptoms among Somali refugees--preliminary communication. Soc Psychiatry Psychiatr Epidemiol (2003) 1.34

Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells. Mol Pharmacol (2006) 1.33

Understandings of environmental quality: ambiguities and values held by environmental professionals. Environ Manage (2003) 1.32

Blood volume perturbations in the postural tachycardia syndrome. Am J Med Sci (2007) 1.31

Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats. J Pharmacol Exp Ther (2005) 1.28

Autonomic failure in neurodegenerative disorders. Semin Neurol (2003) 1.27

Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod Pathol (2008) 1.26

Endurance exercise training in orthostatic intolerance: a randomized, controlled trial. Hypertension (2005) 1.25

A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci U S A (2006) 1.23

Cardiovascular regulation during apnea in elite divers. Hypertension (2009) 1.19

Increased sympathetic activation in idiopathic orthostatic intolerance: role of systemic adrenoreceptor sensitivity. Hypertension (2002) 1.18

Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles. Circulation (2004) 1.17

Orthostatic hypertension: when pressor reflexes overcompensate. Nat Clin Pract Nephrol (2006) 1.17

Spanish genetic admixture is associated with larger V(O2) max decrement from sea level to 4338 m in Peruvian Quechua. J Appl Physiol (1985) (2003) 1.16

Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells. J Immunol (2008) 1.16

Human muscle sympathetic nerve activity and plasma noradrenaline kinetics in space. J Physiol (2002) 1.15

A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. J Neurosci (2003) 1.15

Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med (2002) 1.15

Canadian residents teaching and learning psychiatry in Ethiopia: a grounded theory analysis focusing on their experiences. Acad Psychiatry (2010) 1.14

Current concepts in orthostatic hypotension management. Curr Hypertens Rep (2013) 1.13

Diabetic hypertensive leptin receptor-deficient db/db mice develop cardioregulatory autonomic dysfunction. Hypertension (2008) 1.12

Dishevelled (Dvl-2) activates canonical Wnt signalling in the absence of cytoplasmic puncta. J Cell Sci (2005) 1.12